Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
about
Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects.Normalization of Exhaled Carbonyl Compounds After Lung Cancer Resection.Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.Progress and prospects of early detection in lung cancer.Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer.
P2860
Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Blinded Validation of Breath B ...... cillary to Chest CT Screening.
@ast
Blinded Validation of Breath B ...... cillary to Chest CT Screening.
@en
type
label
Blinded Validation of Breath B ...... cillary to Chest CT Screening.
@ast
Blinded Validation of Breath B ...... cillary to Chest CT Screening.
@en
prefLabel
Blinded Validation of Breath B ...... cillary to Chest CT Screening.
@ast
Blinded Validation of Breath B ...... cillary to Chest CT Screening.
@en
P2093
P2860
P1433
P1476
Blinded Validation of Breath B ...... ncillary to Chest CT Screening
@en
P2093
Cassie Lebauer
Mayur Mundada
Michael Phillips
Naren Ramakrishna
Renee N Cataneo
Thomas L Bauer
William N Rom
P2860
P304
P356
10.1371/JOURNAL.PONE.0142484
P407
P577
2015-12-23T00:00:00Z